{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:59Z","timestamp":1792784939478,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Aichi Cancer Center Joint Research Project on Priority Areas Grant Reference Number: N\/S","id":[{"id":"https:\/\/ror.org\/03kfmm080","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005694","name":"Hori Sciences and Arts Foundation","doi-asserted-by":"publisher","award":["N\/S"],"award-info":[{"award-number":["N\/S"]}],"id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Promoting Association Asano Foundation for Studies on Medicine Grant Reference Number: N\/S"},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["N\/S"],"award-info":[{"award-number":["N\/S"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"DOI":"10.1038\/s41416-026-03619-3","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:35:01Z","timestamp":1791200101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abundant CD8+ tumor-infiltrating lymphocytes in glioblastoma harbor distinct exhaustion signatures in potentially reactive subsets"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-180X","authenticated-orcid":false,"given":"Takanari","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Demachi-Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Masago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Onoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stratford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-1030","authenticated-orcid":false,"given":"Chin Leng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Platten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9069-7160","authenticated-orcid":false,"given":"Hirokazu","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"3619_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.17","volume":"1","author":"M Weller","year":"2015","unstructured":"Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, et al. Glioma. Nat Rev Dis Prim. 2015;1:15017.","journal-title":"Nat Rev Dis Prim"},{"key":"3619_CR2","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314:2535\u201343.","journal-title":"JAMA"},{"key":"3619_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-020-03448-1","volume":"151","author":"R Medikonda","year":"2021","unstructured":"Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. A review of glioblastoma immunotherapy. J Neurooncol. 2021;151:41\u201353.","journal-title":"J Neurooncol"},{"key":"3619_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101385","volume":"47","author":"T Nejo","year":"2020","unstructured":"Nejo T, Yamamichi A, Almeida ND, Goretsky YE, Okada H. Tumor antigens in glioma. Semin Immunol. 2020;47:101385.","journal-title":"Semin Immunol"},{"key":"3619_CR5","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/neuonc\/noae058","volume":"26","author":"AE Sloan","year":"2024","unstructured":"Sloan AE, Winter K, Gilbert MR, Aldape K, Choi S, Wen PY, et al. NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma. Neuro Oncol. 2024;26:1628\u201337.","journal-title":"Neuro Oncol"},{"key":"3619_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"RG Majzner","year":"2022","unstructured":"Majzner RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM, et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature. 2022;603:934\u201341.","journal-title":"Nature"},{"key":"3619_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","volume":"637","author":"M Monje","year":"2025","unstructured":"Monje M, Mahdi J, Majzner R, Yeom KW, Schultz LM, Richards RM, et al. Intravenous and intracranial GD2-CAR T cells for H3K27M(+) diffuse midline gliomas. Nature. 2025;637:708\u201315.","journal-title":"Nature"},{"key":"3619_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","volume":"596","author":"G Oliveira","year":"2021","unstructured":"Oliveira G, Stromhaug K, Klaeger S, Kula T, Frederick DT, Le PM, et al. Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma. Nature. 2021;596:119\u201325.","journal-title":"Nature"},{"key":"3619_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","volume":"184","author":"ND Mathewson","year":"2021","unstructured":"Mathewson ND, Ashenberg O, Tirosh I, Gritsch S, Perez EM, Marx S, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021;184:1281\u201398.e26.","journal-title":"Cell"},{"key":"3619_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add1016","volume":"15","author":"S Naulaerts","year":"2023","unstructured":"Naulaerts S, Datsi A, Borras DM, Antoranz Martinez A, Messiaen J, Vanmeerbeek I, et al. Multiomics and spatial mapping characterizes human CD8(+) T cell states in cancer. Sci Transl Med. 2023;15:eadd1016.","journal-title":"Sci Transl Med"},{"key":"3619_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-23-0913","volume":"14","author":"AZ Wang","year":"2024","unstructured":"Wang AZ, Mashimo BL, Schaettler MO, Sherpa ND, Leavitt LA, Livingstone AJ, et al. Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population. Cancer Discov. 2024;14:1106\u201331.","journal-title":"Cancer Discov"},{"key":"3619_CR12","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","volume":"24","author":"K Woroniecka","year":"2018","unstructured":"Woroniecka K, Chongsathidkiet P, Rhodin K, Kemeny H, Dechant C, Farber SH, et al. T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma. Clin Cancer Res. 2018;24:4175\u201386.","journal-title":"Clin Cancer Res"},{"key":"3619_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"3619_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41592-021-01142-2","volume":"18","author":"L Song","year":"2021","unstructured":"Song L, Cohen D, Ouyang Z, Cao Y, Hu X, Liu XS. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data. Nat Methods. 2021;18:627\u201330.","journal-title":"Nat Methods"},{"key":"3619_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/bioinformatics\/btz474","volume":"36","author":"R Orenbuch","year":"2020","unstructured":"Orenbuch R, Filip I, Comito D, Shaman J, Pe\u2019er I, Rabadan R, et al. arcasHLA: high-resolution HLA typing from RNAseq. Bioinformatics. 2020;36:33\u201340.","journal-title":"Bioinformatics"},{"key":"3619_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/neuonc\/noad021","volume":"25","author":"S Ajaib","year":"2023","unstructured":"Ajaib S, Lodha D, Pollock S, Hemmings G, Finetti MA, Gusnanto A, et al. GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data. Neuro Oncol. 2023;25:1236\u201348.","journal-title":"Neuro Oncol"},{"key":"3619_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","volume":"5","author":"P Danaher","year":"2017","unstructured":"Danaher P, Warren S, Dennis L, D\u2019Amico L, White A, Disis ML, et al. Gene expression markers of Tumor Infiltrating Leukocytes. J Immunother Cancer. 2017;5:18.","journal-title":"J Immunother Cancer"},{"key":"3619_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"3619_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11060-024-04628-z","volume":"167","author":"T Okamoto","year":"2024","unstructured":"Okamoto T, Mizuta R, Takahashi Y, Otani Y, Sasaki E, Horio Y, et al. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data. J Neurooncol. 2024;167:489\u201399.","journal-title":"J Neurooncol"},{"key":"3619_CR20","doi-asserted-by":"publisher","first-page":"e1007603","DOI":"10.1371\/journal.pcbi.1007603","volume":"16","author":"C Flensburg","year":"2020","unstructured":"Flensburg C, Sargeant T, Oshlack A, Majewski IJ. SuperFreq: Integrated mutation detection and clonal tracking in cancer. PLoS Comput Biol. 2020;16:e1007603.","journal-title":"PLoS Comput Biol"},{"key":"3619_CR21","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356.","journal-title":"Genome Res"},{"key":"3619_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0167-x","volume":"7","author":"NM Davidson","year":"2015","unstructured":"Davidson NM, Majewski IJ, Oshlack A. JAFFA: High sensitivity transcriptome-focused fusion gene detection. Genome Med. 2015;7:43.","journal-title":"Genome Med"},{"key":"3619_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas BJ, Dobin A, Li B, Stransky N, Pochet N, Regev A. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 2019;20:213.","journal-title":"Genome Biol"},{"key":"3619_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03922-7","volume":"21","author":"KS Gaonkar","year":"2020","unstructured":"Gaonkar KS, Marini F, Rathi KS, Jain P, Zhu Y, Chimicles NA, et al. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions. BMC Bioinforma. 2020;21:577.","journal-title":"BMC Bioinforma"},{"key":"3619_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.","journal-title":"Nat Commun"},{"key":"3619_CR26","doi-asserted-by":"crossref","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.e29.","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"3619_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding N, Bormann NL, Kraus G. scRepertoire: An R-based toolkit for single-cell immune receptor analysis. F1000Res. 2020;9:47.","journal-title":"F1000Res"},{"key":"3619_CR28","doi-asserted-by":"publisher","first-page":"e007180","DOI":"10.1136\/jitc-2023-007180","volume":"11","author":"H Komuro","year":"2023","unstructured":"Komuro H, Shinohara S, Fukushima Y, Demachi-Okamura A, Muraoka D, Masago K, et al. Single-cell sequencing on CD8(+) TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer\/testis antigen in non-small cell lung cancer. J Immunother Cancer. 2023;11:e007180.","journal-title":"J Immunother Cancer"},{"key":"3619_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2371556","volume":"13","author":"Y Sugita","year":"2024","unstructured":"Sugita Y, Muraoka D, Demachi-Okamura A, Komuro H, Masago K, Sasaki E, et al. Candidate tumor-specific CD8(+) T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis. Oncoimmunology. 2024;13:2371556.","journal-title":"Oncoimmunology"},{"key":"3619_CR30","doi-asserted-by":"crossref","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189\u201396.","DOI":"10.1126\/science.aad0501"},{"key":"3619_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41587-024-02161-y","volume":"43","author":"CL Tan","year":"2025","unstructured":"Tan CL, Lindner K, Boschert T, Meng Z, Rodriguez Ehrenfried A, De Roia A, et al. Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy. Nat Biotechnol. 2025;43:134\u201342.","journal-title":"Nat Biotechnol"},{"key":"3619_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","volume":"375","author":"FJ Lowery","year":"2022","unstructured":"Lowery FJ, Krishna S, Yossef R, Parikh NB, Chatani PD, Zacharakis N, et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science. 2022;375:877\u201384.","journal-title":"Science"},{"key":"3619_CR33","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/1878-0261.12895","volume":"15","author":"X Li","year":"2021","unstructured":"Li X, Zhou C, Chen K, Huang B, Liu Q, Ye H. Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapy. Mol Oncol. 2021;15:1764\u201382.","journal-title":"Mol Oncol"},{"key":"3619_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05072-0","volume":"9","author":"T Duhen","year":"2018","unstructured":"Duhen T, Duhen R, Montler R, Moses J, Moudgil T, de Miranda NF, et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat Commun. 2018;9:2724.","journal-title":"Nat Commun"},{"key":"3619_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","volume":"40","author":"KI Hanada","year":"2022","unstructured":"Hanada KI, Zhao C, Gil-Hoyos R, Gartner JJ, Chow-Parmer C, Lowery FJ, et al. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. Cancer Cell. 2022;40:479\u201393.e6.","journal-title":"Cancer Cell"},{"key":"3619_CR36","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49:D545\u2013D51.","journal-title":"Nucleic Acids Res"},{"key":"3619_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54569-4","volume":"15","author":"R Barakat","year":"2024","unstructured":"Barakat R, Chatterjee J, Mu R, Qi X, Gu X, Smirnov I, et al. Human single cell RNA-sequencing reveals a targetable CD8(+) exhausted T cell population that maintains mouse low-grade glioma growth. Nat Commun. 2024;15:10312.","journal-title":"Nat Commun"},{"key":"3619_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1756116","volume":"9","author":"A Panda","year":"2020","unstructured":"Panda A, Rosenfeld JA, Singer EA, Bhanot G, Ganesan S. Genomic and immunologic correlates of LAG-3 expression in cancer. Oncoimmunology. 2020;9:1756116.","journal-title":"Oncoimmunology"},{"key":"3619_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11060-021-03721-x","volume":"152","author":"MJ Mair","year":"2021","unstructured":"Mair MJ, Kiesel B, Feldmann K, Widhalm G, Dieckmann K, Wohrer A, et al. LAG-3 expression in the inflammatory microenvironment of glioma. J Neurooncol. 2021;152:533\u20139.","journal-title":"J Neurooncol"},{"key":"3619_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.101305","volume":"42","author":"E Ruffo","year":"2019","unstructured":"Ruffo E, Wu RC, Bruno TC, Workman CJ, Vignali DAA. Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor. Semin Immunol. 2019;42:101305.","journal-title":"Semin Immunol"},{"key":"3619_CR41","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3389\/fimmu.2018.02605","volume":"9","author":"DP Saraiva","year":"2018","unstructured":"Saraiva DP, Jacinto A, Borralho P, Braga S, Cabral MG. HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients\u2019 Response to Neoadjuvant Chemotherapy. Front Immunol. 2018;9:2605.","journal-title":"Front Immunol"},{"key":"3619_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s43018-022-00433-7","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu B, Zhang Y, Wang D, Hu X, Zhang Z. Single-cell meta-analyses reveal responses of tumor-reactive CXCL13(+) T cells to immune-checkpoint blockade. Nat Cancer. 2022;3:1123\u201336.","journal-title":"Nat Cancer"},{"key":"3619_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","volume":"565","author":"DB Keskin","year":"2019","unstructured":"Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 2019;565:234\u20139.","journal-title":"Nature"},{"key":"3619_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-023-06081-w","volume":"617","author":"R Naghavian","year":"2023","unstructured":"Naghavian R, Faigle W, Oldrati P, Wang J, Toussaint NC, Qiu Y, et al. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma. Nature. 2023;617:807\u201317.","journal-title":"Nature"},{"key":"3619_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-024-08552-0","volume":"639","author":"DW Kwok","year":"2025","unstructured":"Kwok DW, Stevers NO, Etxeberria I, Nejo T, Colton Cove M, Chen LH, et al. Tumour-wide RNA splicing aberrations generate actionable public neoantigens. Nature. 2025;639:463\u201373.","journal-title":"Nature"},{"key":"3619_CR46","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/s41588-024-01880-x","volume":"56","author":"HJ Jang","year":"2024","unstructured":"Jang HJ, Shah NM, Maeng JH, Liang Y, Basri NL, Ge J, et al. Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells. Nat Genet. 2024;56:1903\u201313.","journal-title":"Nat Genet"},{"key":"3619_CR47","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.20140484","volume":"211","author":"SB Eckle","year":"2014","unstructured":"Eckle SB, Birkinshaw RW, Kostenko L, Corbett AJ, McWilliam HE, Reantragoon R, et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J Exp Med. 2014;211:1585\u2013600.","journal-title":"J Exp Med"},{"key":"3619_CR48","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","volume":"20","author":"DI Godfrey","year":"2019","unstructured":"Godfrey DI, Koay HF, McCluskey J, Gherardin NA. The biology and functional importance of MAIT cells. Nat Immunol. 2019;20:1110\u201328.","journal-title":"Nat Immunol"},{"key":"3619_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60074-z","volume":"16","author":"T Nejo","year":"2025","unstructured":"Nejo T, Krishna S, Yamamichi A, Lakshmanachetty S, Jimenez C, Lee KY, et al. Glioma-neuronal circuit remodeling induces regional immunosuppression. Nat Commun. 2025;16:4770.","journal-title":"Nat Commun"},{"key":"3619_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2025.03.005","volume":"294-295","author":"T Okamoto","year":"2025","unstructured":"Okamoto T, Mizuta R, Demachi-Okamura A, Muraoka D, Sasaki E, Masago K, et al. Immune prognostic model for glioblastoma based on the ssGSEA enrichment score. Cancer Genet. 2025;294-295:32\u201341.","journal-title":"Cancer Genet"},{"key":"3619_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348:62\u20138.","journal-title":"Science"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03619-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03619-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03619-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:35:05Z","timestamp":1791200105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03619-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":51,"alternative-id":["3619"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03619-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Hirokazu Matsushita received research funding from NEC Corporation under a collaborative research agreement related to this study. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The patients provided consent for the submission of this article to the journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of the Aichi Cancer Center (Approval No. 2022-0-114). The secondary use of archived samples for collaborative research was also approved by the Ethics Committee of the Aichi Cancer Center under a separate protocol (Approval No. 2021-0-219). The original collection of retrospective samples at Okayama University was approved by the Ethics Committee of Okayama University (Approval No. 1603-070). For prospectively collected samples (from 2022 onward), written informed consent was obtained from all participants. For retrospectively collected samples, an opt-out approach was utilized in accordance with the institutional guidelines and requirements of the ethics committees.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}